AI for pharma: strategies, use cases, and secure implementation
AlkunMedia supports pharmaceutical companies in adopting AI, automating processes, and building secure Corporate LLMs for regulated business areas. Our focus is on AI solutions that are professionally sound, documentable, and responsibly deployable in quality-critical environments.
Schedule a discovery callWhat AI in pharma means at AlkunMedia
In the pharmaceutical industry, AI must deliver more than simple automation. What matters is traceability, data integrity, validation, clear accountability, and integration into existing quality and compliance structures such as GxP-adjacent processes.
We therefore do not view AI in pharma as an isolated tool, but as part of a controlled operating model. This includes documentation-adjacent processes, internal research, SOP-related knowledge work, quality-relevant workflows, and the appropriate use of Corporate LLMs in regulated environments.
Services overview
Our support in the pharmaceutical industry begins with a structured assessment of processes, risks, and potentials. Building on this, we develop prioritised use cases, robust roadmaps, and organisationally viable implementation approaches.
Potential & process analysis
Analysis of documentation flows, knowledge work, and quality-adjacent processes to identify meaningful AI application areas in pharmaceutical companies.
Learn more arrow_right_altUse-case design & prioritisation
Evaluation of potential AI use cases by value, risk, compliance relevance, and organisational feasibility.
Learn more arrow_right_altCorporate LLMs & knowledge systems
Design of secure LLM applications for SOP access, internal expertise, regulatory documents, and structured information processes.
Learn more arrow_right_altGovernance, roadmap & implementation
Planning of roles, approvals, validation, control mechanisms, and phased rollout for a robust AI implementation in the pharmaceutical context.
Learn more arrow_right_altTypical use cases
Typical AI use cases in pharma arise where large documentation volumes, recurring knowledge work, and regulatory requirements converge.
Document & SOP assistance
Structuring, reviewing, and preparing documents — embedded in approval and change control processes.
Regulatory & medical research
Targeted research and preparation with source references and clear boundaries.
Quality & deviation documentation
Support for capture, classification, and tracking — without automating approval decisions.
Training & onboarding
Knowledge transfer and orientation for new roles and subject areas.
Internal knowledge systems with Corporate LLMs
Discoverability and assistance across policies, SOPs, and specialist documents — with Corporate LLMs where professionally and organisationally appropriate.
Application areas in the pharmaceutical industry
AI in pharma is most valuable where regulatory requirements, complex information flows, and recurring knowledge work converge.
Quality Assurance
QMS, audits, CAPA, and quality documentation.
Quality Control
Analytics, inspection reports, and laboratory-related documentation.
Regulatory Affairs
Authorisations, variations, and regulatory authority communications.
Medical Affairs
Specialist information, evidence, and internal alignment.
Clinical Operations
Study support, monitoring, and study-related documentation.
Pharmacovigilance-adjacent knowledge processes
Capture, assessment, and structured preparation of safety-relevant information.
Pharma Operations
Operational workflows, handovers, and documentation-intensive routines.
Internal support & knowledge processes
Helpdesk, internal FAQs, and knowledge delivery across business units.
How we work together
Our collaboration follows a structured approach that brings together strategy, prioritisation, pharma-specific requirements, and organisational feasibility.
Kickoff & Target Vision
Shared clarification of goals, scope, and regulatory context — including expectations from QA, IT, and business units.
Current-state analysis & data assessment
Inventory of processes, data quality, system landscape, and relevant documentation paths — as a foundation for sound AI decisions.
Use-case design & prioritisation
Evaluate concrete scenarios and place them in a robust order of priority — by value, risk, and regulatory relevance.
Roadmap
Prioritised initiatives, milestones, and next steps — aligned with resources, approvals, and pharma-specific constraints.
Frequently asked questions
How do you ensure GxP conformity and validation for AI solutions? expand_more
We deliberately align with your quality and IT guidelines: clear roles, documented requirements, approval processes, and — where necessary — alignment with validation and change control. AI does not replace regulatory decisions but supports preparatory and documentation-intensive steps.
Can Corporate LLMs be connected to DMS, QMS, or other systems? expand_more
Yes — the architecture follows your landscape. We clarify access paths, permissions, interfaces, and which content is permissible for retrieval or assistance — ensuring knowledge becomes usable without compromising compliance.
Which data may be used in LLM applications in pharma? expand_more
This depends on classification, purpose limitation, and retention. In the design phase we define data categories, pseudonymisation, hosting and access models — and which content is cleared for assistance. Patient or regulatory raw data is not simply fed in but assessed upfront.
How do we prioritise use cases under regulatory and operational pressure? expand_more
We weight value, risk, effort, and regulatory sensitivity together with your stakeholders. The outcome is a transparent prioritisation — often with a pilot phase, measurable KPIs, and clear stop/go decisions.
Let’s talk about AI in pharma
We clarify with you goals, regulatory context, and the right next steps: from process analysis through Corporate LLMs to a roadmap for your organisation.